Kronos Bio, Inc. Common Stock Underwriting AgreementUnderwriting Agreement • October 5th, 2020 • Kronos Bio, Inc. • Pharmaceutical preparations • New York
Kronos Bio, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [•] shares of the Company’s common stock, par value $0.001 per share (“Stock, and such shares ”the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
INDEMNITY AGREEMENTIndemnity Agreement • October 5th, 2020 • Kronos Bio, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of ___________ _____, 20__, is made by and between KRONOS BIO, INC., a Delaware corporation (the “Company”), and _________________ (“Indemnitee”).
April 30, 2018 Norbert Bischofberger, Ph.D. Re: Employment Letter Dear Norbert:Employment Letter Agreement • October 5th, 2020 • Kronos Bio, Inc. • Pharmaceutical preparations • California
Kronos Bio, Inc. (“Kronos” or the “Company”) is pleased to offer you the position of President and Chief Executive Officer, on the following terms and conditions:
